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Abstract Der f 3 is one of the allergens produced by house dust 
mite Dermatophagoidesfarinae showing serine protease activity. 
Based on its amino acid sequence, a cDNA clone encoding Der 
f 3 was isolated from a cDNA library of D. farinae. Sequencing 
analysis of the clone revealed the presence of an open reading 
frame of 780 bp, which encodes a mature protein of 232 amino 
acids with 27 amino acids of pre-pro sequence at the N-terminus. 
When proDer f 3 was produced in Escherichia coli as a fused 
protein with glutathione-S-transferase, thefused protein was ac- 
cumulated as inclusion bodies. The protein purified with 8 M urea 
and glutathione-affinity column chromatography, however, did 
not show protease activity. When an arginine residue was intro- 
duced at the C-terminus of the pro-region in place of threonine, 
removal of the pro-region to produce an active mature protease 
was observed. The specificity and the activity of this recombinant 
protease were almost the same as those of native Der f 3. 
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1. Introduction 
Dermatophagoides species are known as house dust mite, 
which produce many allergens that cause allergic diseases, such 
as atopic dermatitis and asthma [1-3]. Several allergenic pro- 
teins which reacted with human IgE antibody, resulting in trig- 
gering the allergic symptoms, have been isolated from two 
Dermatophagoides species, D. farinae and D. pteronyssinus [1- 
3]. Der f 3 isolated from D. farinae [4] is one of these allergenic 
proteins belonging to the group-3 allergens. Although its phys- 
iological role in mites is still unknown, it has been shown that 
Der f 3 is a serine protease with trypsin-like activity [5-8], which 
can activate the kallikrein-kinin system involved in various 
allergic reactions in human plasma [9,10]. Over several years 
allergenic properties of Der f 3 have been examined. However, 
various extents of reactivity to IgE (16-100%) were reported 
[4-7]. To measure the exact reactivity of the group-3 allergens 
to IgE antibodies, it is required to establish a system to produce 
Der f 3 in large quantity. Furthermore, a high expression sys- 
tem for allergens may assure analyzing the mechanism of aller- 
gic response as well as diagnosis and treatment of IgE-mediated 
allergy disorders. In case of Der f 2, one of the major house dust 
mite allergens, for example, we have succeeded in the elucida- 
tion of human IgE epitopes for Der f2, by using the Eseherichia 
coli expression system for the allergen [11,12]. By using the 
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expression system, it will also be possible to examine the in- 
volvement of the trypsin-like serine protease activity of Der f 
3 in allergic diseases. We here report the isolation of Der f 3 
eDNA obtained from D. farinae and the production of Der f 
3 in E. coli. 
2. Materials and methods 
2.1. Construction fthe D. farinae 2gtll eDNA library 
The mRNA of D. farinae was purified from a culture of D. farinae 
as described in our previous report [13]. cDNA was synthesized with 
this mRNA and cloned to 2gtl 1 phage DNA using Complete rapid 
cloning system (Amersham). Invitro packaging of the phage DNA with 
D. farinae cDNA and transformation f Escherichia coli Y1090 was 
carried out with Giga pack II packaging extract (Stratagene). 
2.2. Isolation of Der f 3 eDNA clone from the eDNA library 
A DNA fragment was amplified by PCR with the following synthetic 
oligonucleotides as primer and the eDNA library as the template. One 
oligonucleotide 5'-GGGGATCCATTGTTGGTGGTGTTAAAGCA- 
3' was designed from the N-terminus amino acid sequence of native Der 
f 3 [6] containing a BamHI site at its 5'-end, and the other was from 
a sequence of Agtl 1, 5'-GGTGGCGACGACTCCTGGAGCCCG-Y. 
PCR was performed by repeating the thermal cycle (94°C for 1 min, 
55°C for 2 rain, and 72°C for 3 rain) 25 times with a thermal cycler 
RC-700 (Astec, Japan). About 1000 bp of the PCR fragment was 
amplified. After digestion with BamHI plus EcoRI, the DNA fragment 
was subcloned into plasmid, pBluescript II, and introduced into E. coli 
DH5~. The resulting plasmid was purified with QIAGEN plasmid 
Midi-kit (QIAGEN) and digested with BamHI plus EeoRI. The resul- 
tant DNA fragment was labeled with ECL direct nucleic acid labeling 
system (Amersham) and used as the probe for plaque hybridization. 
The plaque eDNA library was plated on a 90 mm petri dish at about 
10,000 pfu per dish and transferred onto the Hybond-N+ membrane 
filter (Amersham) according to the supplier's instruction. Hybridiza- 
tion was performed with ECL detection system (Amersham). One pos- 
itive clone was obtained from about 50,000 plaques and isolated by the 
secondary screening. The phage DNA was purified from this positive 
clone using QIAGEN Lambda Midi kit (QIAGEN). 
2.3. Sequence analysis of Der f 3 cDNA 
The phage DNA with Der f 3 eDNA sequence was digested with 
EcoRI plus ClaI and subcloned into pBluescript II. The DNA sequence 
of Der f 3 eDNA was verified by the dideoxy-chain termination method 
[14] using an Applied Biosystems 370A sequencer. 
2.4. Construction fexpression plasmids 
To introduce a BamHI site at upstream of the pro-region and HindlII 
site just downstream ofthe stop codon for Der f 3, PCR was performed 
using the eDNA of Der f 3 as template, and the following synthetic 
oligonucleotides as primers: one (primer A) is 5'-AGTGGATCCAC- 
ACCGATTCTTCCATCA-3', and the other (primer B) is 5"-CGAA- 
GCTTACTGTGAACGTTTTGATTCAAT-3'. The reaction condi- 
tion of the PCR is the same as described above. After digestion with 
BamHI plus HindlII, the amplified DNA fragment was subcloned into 
the expression plasmid pGEX-4T-2 (Pharmacia Biotech). The resulting 
plasmid was designated pGEX/proDer f 3. In this construction, proDer 
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f 3 was produced as a fusion protein (GST-proDer f 3) composed of 
glutathione-S-transferase and proDer f 3 protein linked with a dipep- 
tide (Gly-Ser). Another expression plasmid pGEX/T(-1)R-proDer f 3, 
which has almost an identical construction to that of pGEX/proDer f 
3 but with replacement of the codon (ACT) for Thr at the C-terminus 
of the pro-region by CGT for Arg, was constructed by site-directed 
mutagenesis u ing PCR as the similar method described above. Two 
synthetic oligonucleotides 5"-GCGGATCCACACCGATTCTTCCA- 
TCATCACCAAATGCACGT-Y for introducing the mutation, and 
5'-CGAAGCTTACTGTGAACGTTTTGATTCAAT-3' which is the 
same as primer B used for the construction of the pGEX/proDer f 3, 
was used as the primer for PCR. The resulting PCR fragment was 
digested with BamHl plus HindlII and subcloned into pGEX-4T-2. 
ProDer f 3 T(-1)R was produced in E. coli BL21 harboring the result- 
ing plasmid, pGEX/T(- 1)R-proDer f 3, as inclusion bodies as the same 
as above. 
2.5. Production and purification of recombinant fusion protein 
Overnight culture of E. coli BL21 carrying pGEX/proDer f 3 grown 
in L-broth containing 50 pg/ml of ampicillin, was diluted to 100-fold 
with the same medium and further cultured for 2 h at 30°C. lsopropyl- 
,8-D-thiogalactopyranoside (IPTG) was added to a final concentration 
of 100 pM to induce the tac promoter. After an additional 4 h incuba- 
tion at 30 °C, the E. coli cells were harvested by centrifugation, resus- 
pended in the buffer containing 100 mM Tris-HCl and 10 mM EDTA 
(pH 9.0), and disrupted by sonication. Since GST-proDer f 3 was 
produced as inclusion bodies, the fused protein was precipitated by 
centrifugation at7000 x g for 15 miu. This insoluble protein was solu- 
bilized with 8 M urea containing 20 mM Tris-HC1 (pH 9.0) and dialyzed 
against 20 mM Tris-HC1 (pH 9.0) for renaturation for 4 h. After succes- 
sive dialysis against PBS [11] for 2 h, the solution containing GST- 
proDer f 3 was applied onto a column of glutathione-Sepharose 4B 
equilibrated with PBS and eluted with 50 mM Tris-HCl (pH 8.0) con- 
taining 10 mM reduced glutathione. The GST-proDer f 3 thus purified 
was digested with thrombin (1 U per mg protein) for more than 2 h at 
room temperature to produce proDer f 3 with additional two amino 
acids at N-terminus. Purified proDer f 3 was obtained by collecting 
passing fraction through the successive glutathione-Sepharose 4B col- 
umn chromatography. 
2.6. Electrophoresis and Western blotting 
The protein samples were subjected to SDS-polyacrylamide g lelec- 
trophoresis under reducing conditions and transferred onto nitrocellu- 
lose membrane (Bio-Rad) for Western blotting analysis. After blocking 
with PBS containing 0.05% (w/v) Tween 20 for 1 h at room temperature, 
the membrane was incubated with allergic patient sera diluted to 1/4 
by 0.05% Tween-PBS, overnight at 4°C. After washing three times with 
0.05% Tween-PBS, horseradish peroxidase-conjugated goat anti- 
human IgE antibody (Cappel) diluted to 1/1000 by 0.05% Tween-PBS 
was applied to the membrane as secondary antibody. After incubation 
for more than 5 h at room temperature, the membrane was washed with 
PBS as the same as above, and 30 mg of 1-chloro-4-naphtol resolved 
in 10 ml of methanol and 50 ml of PBS containing 0.03% H202 was 
applied onto the membrane as substrate. 
2. 7. Measurement of protease activity 
Protease activity of wild-type or mutant Der f 3 was measured using 
synthetic substrates. Forty pM of synthetic substrate (Boc-Q-G-R- 
MCA, Boc-F-S-R-MCA, Boc-V-L-K-MCA, Suc-L-L-V-Y-MCA, or 
Suc-A-A-P-F-MCA) in 1 ml of 50 mM of Tris-HC1, pH 8.0 was incu- 
bated at 37°C after addition of an appropriate amount of wild-type or 
mutant Der f 3. The amount of 7-amino-4-methylcoumarin (AMC) 
released from synthetic substrates was determined by measuring the 
fluorescence at 380 nm for excitation, and at 460 nm for emission on 
a fluorometer (Hitachi S-2000 fluorescence spectrophotometer, 
Tokyo). 
2.8. PCR-based cloning of Der f 3 cDNA 
To examine the polymorphism ofDer f3 in dust mite, PCR was again 
performed using D. farinae cDNA library as template, and two primers, 
primers A and B, used in the construction of expression plasmid for 
wild-type Der f 3. The DNA fragment amplified by PCR in the same 
conditions as above was subcloned into pBluescript II, and the nucleo- 
tide sequence of Der f 3 clones were determined. 
3. Results and discussion 
3.1. Cloning and sequence of Der f 3 cDNA 
Based on N-terminal amino acid sequence of Der f 3 already 
reported, an oligonucleotide was synthesized. When PCR was 
carried out together with another oligonucleotide having the 
sequence for a part of 2gtl  1, a single DNA fragment of about 
1000 bp was amplified, Nucleotide sequencing revealed that the 
amplified fragment contained the sequence which corresponds 
to the amino acid sequence for Der f 3. We therefore used this 
fragment as a probe for plaque hybridization to clone Der f 3 
cDNA. A single Der f 3 clone was obtained from about 50,000 
clones of D. farinae cDNA library by plaque hybridization. The 
nucleotide sequence and the amino acid sequence deduced from 
the nucleotide sequence was shown in Fig. 1. The cDNA was 
1043 bp in length and contained a single open reading frame 
of 780 bp which started from ATG (nt 46) and terminated at 
stop codon TGA (nt 823). The N-terminal amino acid sequence 
ATTTT CCAA TTAACAAATAAATCGTATATTGAAATCG 38 
-2O 
AACCAAG ATG AT(; ATT TTA ACC ATT GTC GTG TTA TTG GCT GCA AAC ATT 87 
Met Met Ile L~u Thr 11e Val Val Leu Leu Ala Ala ASh lle 
-10 - I  1 
TTG GCC ACA CCG ATT CTT CCA TCA TCA CCA AAT GCA ACT ATT GTT GGT 135 
Leu Ala Thr Pro Ile Leu Pro S~r Set Pro ASh Ala Thr lle Val Giy 
10 
GGT GTG AAA GCA CAA GCC GGT GAT TGT CCA TAT CAA ATT TCA TTG CAA 183 
Gly Val Lys Ala Gln Ala G1y Asp Cys Pro Tyr Gln lie Set Leu Gln 
20 30 
TCA AGC AGC CAT TTT TGT GGT GGT AGT ATC CTG GAT GAA TAT TGG ATC 231 
Set Set Set His Phe Cys G1y Gly Set Ile Leu ASp Glu Tyr Trp lle 
4t0 50 
TTG ACC GCT GCA CAT TGT GTC AAT GGA CAA TCA G~A AAA AAA CTT TCA 279 
Leu ThE Ala Ala His Cys Val Ash Gly Gin Sel AI~ Ly8 Lys Leu Set 
60 
ATT CGT TAC AAT ACT CTT AAA CAT GCA TCT GGT GGT GAA AAG ATT CAA 327 
lle Arg Tyr Ash Thr Leu Lys His Ala Set Gly Gly G1u Lye Ile Gln 
70 80 
GTG GCG GAA ATT TAT CAA CAT ~AA AAT TAT GAT AGC ATG ACT ATC GAT 375 
Val Ala GIu Ile Tyr Gin RiB GIu ASh Tyl ASp Set Met Thr lie Asp 
90 
AAT GAT GTT GCA TTG ATA AAA CTC AAA ACA CCA ATG ACA TTG GAT CAA 423 
ASh Asp Val Ala Leu Ile Lys Leu Lys Thr Pro Met Thr Leu ASp Gin 
100 110 
ACA AAT GCT AAA CCC GTA CCA TTA CCA GCA CAA GGA TCA GAT GTA AAA 471 
ThE ASh Ala Lys Pro Val Pro Leu Pro Ala Gln Gly Set Asp Val Lyu 
120 130 
GTT GGT GAT AAA ATT CGT GTT TCT GGT TGG GGT TAT CTT CAG GAA GGA 519 
Val Gly ASp Lys I1e Arq Val Set Gly Trp Gly Tyr Let Gln Glu Giy 
140 
AGT TAT TCA TTA CCA TCG GAA TTA CAA CGT GTT GAT ATT GAT GTT GTA 567 
Set Tyr Set Leu Pro Set Glu Leu Gin Arg Val A~p I1e ASp Val Val 
150 160 
TCA CGT GAA CAA TGT GAC CAA TTA TAT TCA AAA GCA GGC GCC GAT GTT 615 
Set Arg Glu Gln Cys Asp Gin Leu Tyr Set Lys Ala Gly Ala Asp Val 
170 
AGT GAA AAT ATG ATT TGC GGC GGT GAT GTC GCT AAT GGT GGT GTT GAT 663 
Set Glu ASh Met Ile Cys Gly GIy Asp Val A1a Ash GIy Gly Val Asp 
180 190 
TeA TGT CAA GGT GAT TCT GGC GGA CCA GTT GTT GAT GTT GCC ACT AAA 711 
Set Cys Gln Gly Asp Set Gly Gly Pro Val Val ASp val Ala Thr Lys 
200 210 
CAA ATT GTT GGT ATT GTT TCA TGG GGT TAT GGT T~T GCA CGT AAA GGT 759 
Gin I1e Val GIy I1e Val Set Trp Gly Tyr Gly Cys Ala Arg Lys Gly 
220 
TAT CCA GGT GTC TAT ACA CGT GTT GGT AAT TTT GTC GAT TGG ATT GAA 807 
Tyr PrO Gly Val Tyr Thr Arg Yal G1y Ash Phe Val Asp Trp Ile Glu 
230 
TCA AAA CGT TCA CAG TGA ATGATAAAATGC~CAACAACGGTCACAATGGCACGATAAT 864 
Set Lys Arg Set Gln Trm 
ACACCCT TAC GTGCAATCATTATGTTTTTTATAAT~/TCTTTT TTC TTCTATCTCTTTATTTT 927 
TTATCGAAAGTAAAAAAACAGCAAAATCAATATTGACTTAAGAGAATTGATTTTTGTTTCGAA 990 
Fig. 1. Nucleotide and deduced amino acid sequences ofDer f 3 cDNA. 
The nucleotide sequence data reported in this paper is registered in the 
DDBJ, EMBL, and GenBank nucleotide sequence databases under the 
accession umber D63858. 
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Fig. 2. IgE-binding ability of recombinant proDer f 3 analyzed by 
Western blotting. Lanes 1, 3, 5, and 7, GST-proDer f 3 digested with 
thrombin; lanes 2, 4, 6, and 8, GST-proDer f 3 fused protein. Lanes 1 
and 2, Coomassie brilliant blue staining. IgE antibodies used are: lanes 
3 and 4, pooled patient sera A; lanes 5 and 6, pooled patient sera B; 
lanes 7 and 8, serum from an atopic patient. 
of the first 20 amino acids of mature Der f 3 already determined 
was found in the deduced amino acid sequence from the 28th 
to the 47th of the open reading frame, suggesting that Der f 3 
was produced as a precursor with a N-terminal extension of 27 
amino acids. Der f 3 is known to have a trypsin-like serine 
protease activity [5-8]. Pancreatic trypsin was produced as a 
precursor with a N-terminal extension of over 20 amino acids 
[15,16]. N-terminal part 15 amino acids of the extension serves 
as the signal sequence for secretion and C-terminal part 6-9 
amino acids of the extension is known as pro-segment in tryp- 
sin. N-terminal portion (lst to 16th) of the extension of Der f 
3 protein had high hydrophobic amino acid sequence, which is 
a typical feature of signal sequence for secretion. We assume 
that the N-terminal extension of Der f 3 was divided into two 
functional parts, pre-sequence (lst to 16th) for secretion and 
pro-sequence (17th to 27th) probably for folding as will be 
described below. For exact understanding of the role of the 
N-terminal segment further study will be required. By align- 
ment of the amino acid sequence of the trypsin family, the 
catalytic-triad of Der f 3, which is essential for the enzyme 
activity, was assigned to His-40, Asp-85 and Ser-185. One hun- 
dred and seventy bp downstream of the termination codon, the 
sequence AATAAA is present, which may serve as a poly(A) 
signal to the 3' terminus of the mRNA for Der f 3 [17]. 
3.2. Human IgE binding ability of recombinant Der f 3 
The binding ability of recombinant proDer f 3 to human IgE 
antibodies from patients era was studied by Western blotting 
analysis. The proDer f 3 expressed as a fusion protein with GST 
actually bound to human IgE antibodies from every serum used 
as shown in Fig. 2. When similar analysis was carried out with 
the preparation of GST-proDer f 3 treated with thrombin, the 
human IgE antibodies reacted with proDer f 3 portion, while 
only negligible binding was observed to the GST portion. 
3.3. Protease activity of recombinant Der f 3 
As described above, Der f 3 is known to be a trypsin-like 
serine protease [5-8]. Therefore, the protease activity and sub- 
strate specificity could become an index for correct refolding 
of Der f 3 protein from inactive inclusion bodies. When either 
of refolded GST-proDer f 3-fused protein or proDer f 3 portion 
purified from refolded GST-proDer f 3-fused protein was used, 
no protease activity was observed, although both recombinant 
proDer f 3 proteins showed IgE-binding activity. Trypsin or 
kallikrein, which has the protease activity to cleave the peptide 
bond of C-terminal side of Arg and/or Lys, have Arg or Lys 
residues at the C-terminal end of its own pro-segment, and was 
therefore activated by an autocatalytic process to remove the 
pro-region in intra- and/or inter-molecule manner [18]. On the 
other hand, despite that native Der f 3 was shown to have 
Arg-and Lys-specific leavage activity [6,7], a C-terminal resi- 
due of the pro-segment of proDer f 3 is Thr. Pro-sequence of 
protease is known to have a role in correct folding. Further- 
more, pro-sequence can be regarded as a specific inhibitory 
segment maintaining the protease in an inactive form, which 
protects the cell from the attack by the protease under unfavor- 
able conditions. Therefore, it was probable to think that the 
failure of proDer f 3 in showing protease activity resulted from 
inability to cleave the Thr(-1)-Ile-1 peptide bond due to less 
specificity to this peptide bond. We, therefore, replaced 
Thr(-1) by Arg. The mutant Der f 3 containing T ( - l )R  re- 
placement was produced as a fusion protein like the case for 
wild-type in a form of inclusion bodies in E. coli cells. During 
the refolding process by dialysis against Tris-HC1 buffer to 
remove urea, proteolytic activity to remove the N-terminal pro- 
region was observed, while such processing was not found with 
GST-wild-type proDer f 3. This processing was inhibited by the 
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Fig. 3. Amino acid sequence variation in Der f 3. The amino acid 
residues which differ from those deduced from the nucleotide sequence 
determined with the cDNA were indicated. Der f 3 A, B, and C indicate 
the N-terminal amino acid sequences of Der f 3 reported in other 
publications, [10], [4], and [6], respectively. The nucleotide sequences of
primers A and B are shown in section 2, 
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Table 1 
Comparison of protease activity between recombinant Der f 3 and 
native Der f 3 
Relative protease activity (%) 
Synthetic substrates Recombinant Native Der f 3 
Der f 3 Aa Ba cb 
T(-1)R ° 
Boc-Q-G-R-MCA 100 105 N.D. 100 
Boc-F-S-R-MCA 100 100 100 N.D. 
Boc-V-L-K-MCA 50 50 58 43 
Suc-L-L-V-Y-MCA 2 30 0 0 
Suc-A-A-P-F-MCA 0 0 0 N.D. 
Protease activity was measured with the method reported previously [9]. 
Relative protease activities, A B, and C, of native Der f 3 purified from 
house dust mite were quoted from three different references, [6], [7], and 
[10], respectively. 
aProtease activities with Boc-F-S-R-MCA were expressed as 100%. 
bprotease activities with Boc-Q-G-R-MCA were expressed as 
100%. 
N.D., not determined. 
addition ofp-aminobenzamidine or l upeptine, which is known 
as a serine protease inhibitor (data not shown). Renatured 
GST-proDer f 3 T(-1)R fraction was then applied onto a 
DEAE-Toyopearl column and a major peak was collected. 
When the pooled fractions were subjected to SDS-PAGE, the 
fraction was found to contain only two proteins, one was GST 
and the other was the protein cross-reactive to sera from aller- 
gic patients to house dust mite (data not shown). When the 
N-terminal 20 amino acid sequence of the latter protein was 
determined by automated Edman degradation, a sequence 
identical to that of mature Der f 3 was obtained, indicating that 
the replacement a position -1 caused the correct processing 
to produce mature Der f 3. With this preparation containing 
mature Der f 3, the relative protease activity of Der f 3 was 
determined using synthetic substrates (Table 1). The substrate 
specificity of recombinant Der f 3 was almost he same as that 
of native Der f 3. Since we have not yet obtained pure recom- 
binant Der f 3 preparation because of further degradation dur- 
ing the refolding process, quantitative characterization f the 
enzyme activity of the recombinant Der f 3 has not yet been 
performed. However, based on the densitometric estimation of 
the amount of purified recombinant Der f 3, recombinant Der 
f 3 has specific activity almost identical to that of native Der 
f 3 (data not shown). This study showed that proDer f 3 did 
not have the ability to produce mature nzyme. This may sug- 
gest that another protease which convert proDer f 3 to the 
active form is present in dust mite. 
3.4. Polymorphism olDer f3  
We obtained a single clone of Der f 3 cDNA as described 
above. The amino acid sequence of 20 residues at N-terminus 
deduced from the nucleotide sequence was identical to that of 
the native Der f 3 reported by Ando et al. [6] and Kohmoto et 
al. [10] but was somewhat different to that by Heymann et al. 
[4] as shown in Fig. 3. Since polymorphism is found in other 
house dust mite allergens, Der p 1 [19] and Der f 2 [11,13], the 
amino acid variation in the reported sequences might be due 
to polymorphism. To examine the possibility, we tried to clone 
other-type Der f 3 cDNAs by PCR. Although PCR clones 
directing the amino acid sequence reported by Heymann was 
not isolated, three different clones for Der f 3 were obtained. 
65 
The amino acid sequences deduced from the nucleotide se- 
quences were shown in Fig. 3. We designated these clones as 
PCR clone-type 1, -type 2, and -type 3. Among 7 PCR-clones 
sequenced, 1 was classified to type 1, 5 were type 2, and one 
was type 3. The amino acid sequence of PCR-clone-type 1 is 
identical to that of cDNA we first isolated. The amino acid 
sequence of PCR-clone-type 2 has a single amino acid replace- 
ment at the 5th residue. On the other hand, PCR-clone-type 3 
has amino acid variations at five positions, which is identical 
to that deduced from the nucleotide sequence of PCR-amplified 
Der f 3 DNA fragment used as the probe for the first plaque 
hybridization. In the case of Der f 2, which also shows polymor- 
phism, a mite has a single Der f 2 gene (unpublished result). 
Therefore, we at present speculate that each mite has only one 
gene for Der f 3. To clarify this possibility, further study will 
be obviously required. Amino acid variations found in this 
study may give a clue to clarify the epitopes to IgE antibodies 
of this allergen. In every clone, the amino acid sequence at the 
-1 position is Thr. Furthermore, Der p 3 which is also a group- 
3 allergen produced by D. pteronyssinus has Thr at position -1 
[20]. Tryptase, a trypsin-like serine protease, is produced as a 
precursor with a N-terminal pro-segment. This precursor is 
known to be converted to an active form by another protease 
which cleaves the peptide bond of Gly-Ile at the pro-mature 
junction [21]. From these observations, we assume that group-3 
allergens are converted to an active form from the precursor 
by the mechanism ediated by some other factors. 
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